However, a recent study searching for BCR-ABL- and ABL-BCR-derived neoepitopes in 21 CML patients, including eight HLA-A*03-positive patients, could not detect any naturally presented neoepitopes by LC-MS/MS analysis [104]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.